Endoluminal Sciences is a medical technology company that has developed a proprietary polymer-based platform technology to dramatically enhance the clinical performance of endovascular prostheses. While the technology is foreseen to have its applications in the treatment of a range of vascular disease states, the current focus is the treatment of structural heart disease and aortic aneurysmal disease. Our unique approach uses a combination of mechanical engineering and polymer science to overcome key failure modes of endovascular devices, particularly related to para-prosthetic leakage, in a manner superior to any device currently in clinical trials or on the market. 

 

The technology and knowhow originates from the founders' work at Stanford University, California, USA and The University of Sydney, New South Wales, Australia.